Menu

• Ask a Health Expert about PLASMACYTOMA
• Post Your Side Effect related to PLASMACYTOMA
• PLASMACYTOMA and FDA Warnings
• PLASMACYTOMA in Patients Wiki
• Report PLASMACYTOMA in Drug Side Effect Survey

PLASMACYTOMA side effect

What is PLASMACYTOMA ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Remicade Side Effects Report #5562842-9
Physician from UNITED STATES reported REMICADE problem on Dec 06, 2007. Female patient, 58 years of age, was diagnosed with crohn's disease and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: plasmacytoma, . REMICADE dosage: unknown. Patient recovered.

Methotrexate Side Effects Report #5573736-7
METHOTREXATE problem was reported by a Health Professional from JAPAN on Dec 24, 2007. Female patient, 39 years of age, was diagnosed with prophylaxis against graft versus host disease and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: plasmacytoma, . METHOTREXATE dosage: unknown. During the same period patient was treated with CYCLOSPORINE. Patient recovered.

Velcade Side Effects Report #5458066-6
Health Professional from UNITED KINGDOM reported VELCADE problem on Sept 04, 2007. Female patient, 55 years of age, was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: plasmacytoma, . VELCADE dosage: unknown. Patient recovered.

Remicade Side Effects Report #5382602-1
REMICADE problem was reported by a Physician from UNITED STATES on June 29, 2007. Female patient, weighting 164.0 lb, was diagnosed with crohn's disease and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: plasmacytoma, . REMICADE dosage: unknown. Patient recovered.


Remicade Side Effects Report #5382602-1
Physician from UNITED STATES reported REMICADE problem on June 29, 2007. Female patient, weighting 164.0 lb, was diagnosed with crohn's disease and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: plasmacytoma, . REMICADE dosage: unknown. Patient recovered.

Humira Side Effects Report #5350542-X
HUMIRA problem was reported by a Consumer or non-health professional from FRANCE on June 01, 2007. Male patient, weighting 185.2 lb, was diagnosed with rheumatoid arthritis, hypertension, depression, hypothyroidism, prophylaxis against gastrointestinal ulcer and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: plasmacytoma, . HUMIRA dosage: unknown. During the same period patient was treated with COMMERCIAL HUMIRA, FLECAINIDE ACETATE, BISOPROLOL FUMARATE, VENLAFAXINE, LEVOTHYROXINE, PROPRANOLOL, POTASSIUM CHLORIDE, ZOLPIDEM. Patient was hospitalized. Patient recovered.

Humira Side Effects Report #5358688-7
Consumer or non-health professional from GERMANY reported HUMIRA problem on June 12, 2007. Male patient, weighting 187.4 lb, was diagnosed with rheumatoid arthritis, gastrooesophageal reflux disease and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: plasmacytoma, . HUMIRA dosage: unknown. During the same period patient was treated with METHOTREXATE, METHYLPREDNISOLONE, ESOMEPRAZOLE MAGNESIUM, PLEA RA, ROFECOXIB, HUMIRA`. Patient recovered.

Humira Side Effects Report #5359375-1
HUMIRA problem was reported by a Consumer or non-health professional from FRANCE on June 11, 2007. Male patient, weighting 185.2 lb, was diagnosed with rheumatoid arthritis, hypertension, depression, hypothyroidism, prophylaxis against gastrointestinal ulcer and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: plasmacytoma, . HUMIRA dosage: unknown. During the same period patient was treated with COMMERCIAL HUMIRA, FLECAINIDE ACETATE, BISOPROLOL FUMARATE, VENLAFAXINE, LEVOTHYROXINE, PROPRANOLOL, POTASSIUM CHLORIDE, ZOLPIDEM. Patient was hospitalized. Patient recovered.

Thalomid Side Effects Report #5341337-1
Physician from UNITED STATES reported THALOMID problem on May 18, 2007. Female patient, 58 years of age, was diagnosed with multiple myeloma and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: plasmacytoma, postoperative wound complication, wound necrosis, . THALOMID dosage: 100 MG, (DAILY), ORAL. During the same period patient was treated with CELEXA, LISINOPRIL, CYCLOBENZAPRINE, SULAR, ATENOLOL, CALCIUM, VITAMIN D, DEXAMETHASONE. Patient was hospitalized. Patient recovered.


Revlimid Side Effects Report #5772844-5
REVLIMID problem was reported by a Physician from UNITED STATES on June 03, 2008. Female patient, 62 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, plasmacytoma, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with ASPIRIN, PREVACID, DEXAMETHASONE, ATENOLOL, VICODIN, ALEVE. Patient died on 05/27/2008.

Insulin Side Effects Report #5749315-5
Health Professional from CROATIA (local name: Hrvatska) reported INSULIN GLARGINE problem on May 20, 2008. Male patient, 72 years of age, was diagnosed with diabetes mellitus, acute myocardial infarction and was treated with INSULIN GLARGINE. After drug was administered, patient experienced the following problems/side effects: multiple myeloma, plasmacytoma, renal failure acute, . INSULIN GLARGINE dosage: unknown. During the same period patient was treated with OPTIPEN, GLYBURIDE, ACETYLSALICYLIC ACID SRT, RAMIPRIL, ISOSORBIDE DINITRATE, ATORVASTATIN CALCIUM, PANTOPRAZOL. Patient was hospitalized and became disabled. Patient recovered.

Thalomd Side Effects Report #5343656-1
THALOMD problem was reported by a Physician from UNITED STATES on May 18, 2007. Female patient, 57 years of age, was diagnosed with multiple myeloma and was treated with THALOMD. After drug was administered, patient experienced the following problems/side effects: impaired healing, plasmacytoma, post procedural complication, soft tissue necrosis, . THALOMD dosage: 100 MG, DAILY, ORAL. During the same period patient was treated with CELEXA, LISINOPRIL, CYCLOBENZAPRINE, SULAR, ATENOLOL, CALCIUM, VITAMIN D, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Gleevec Side Effects Report #5266056-1
Physician from reported GLEEVEC problem on Mar 02, 2007. Male patient, 75 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: myocardial infarction, plasmacytoma, surgery, . GLEEVEC dosage: 300 MG DAILY. Patient recovered.

Clozapine Side Effects Report #5662835-7
CLOZAPINE problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 25, 2008. Male patient, 33 years of age, weighting 173.0 lb, was diagnosed with schizophrenia, multiple myeloma and was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: humerus fracture, multiple myeloma, plasmacytoma, pyrexia, . CLOZAPINE dosage: 200 MG; TWICE A DAY; ORAL. During the same period patient was treated with DECADRON, BACTRIM, VELCADE, REVLIMID, VALTREX, ASPIRIN, ZOMETA, DEPAKOTE. Patient was hospitalized. Patient recovered.


Methotrexate Side Effects Report #5576425-8
Health Professional from JAPAN reported METHOTREXATE problem on Dec 27, 2007. Female patient, 39 years of age, was diagnosed with prophylaxis against graft versus host disease and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: brain compression, no therapeutic response, plasmacytoma, viith nerve paralysis, . METHOTREXATE dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, DOXORUBICIN, CYCLOSPORINE, DEXAMETHASONE, MELPHALAN. Patient recovered.

Prograf Side Effects Report #5500631-1
PROGRAF problem was reported by a Health Professional from UNITED STATES on Oct 11, 2007. Male patient, 67 years of age, weighting 145.1 lb, was diagnosed with prophylaxis against transplant rejection and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: multiple myeloma, paraproteinaemia, plasmacytoma, pleural effusion, . PROGRAF dosage: 5 MG, BID, ORAL. During the same period patient was treated with CELLCEPT, RAPAMYCIN. Patient died on 07/27/2007.

Thalomid Side Effects Report #5402046-3
Physician from UNITED STATES reported THALOMID problem on July 23, 2007. Male patient, 81 years of age, was diagnosed with plasmacytoma and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: abasia, condition aggravated, plasmacytoma, . THALOMID dosage: 100 MG, 1 IN 1 D, ORAL. Patient recovered.

Thalomid Side Effects Report #5402046-3
THALOMID problem was reported by a Physician from UNITED STATES on July 23, 2007. Male patient, 81 years of age, was diagnosed with plasmacytoma and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: abasia, condition aggravated, plasmacytoma, . THALOMID dosage: 100 MG, 1 IN 1 D, ORAL. Patient recovered.

Bupivacaine Side Effects Report #5319200-1
Physician from GERMANY reported BUPIVACAINE problem on Apr 26, 2007. Male patient, 61 years of age, weighting 169.8 lb, was treated with BUPIVACAINE. After drug was administered, patient experienced the following problems/side effects: extradural haematoma, paraplegia, plasmacytoma, . BUPIVACAINE dosage: unknown. Patient was hospitalized. Patient recovered.


Forteo Side Effects Report #5330159-3
FORTEO problem was reported by a Consumer or non-health professional from UNITED STATES on May 08, 2007. Male patient, 71 years of age, was diagnosed with osteoporosis and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: fall, gait disturbance, plasmacytoma, . FORTEO dosage: unknown. During the same period patient was treated with LOVASTATIN. Patient was hospitalized. Patient recovered.